RDY
Dr. Reddy’s Laboratories Ltd ADR
NYSE: RDY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$13.73
-2.14% today
Updated 2026-04-29
Market cap
$11.46B
P/E ratio
19.07
P/S ratio
0.03x
EPS (TTM)
$0.72
Dividend yield
0.67%
52W range
$13 – $16
Volume
2.4M
Dr. Reddy’s Laboratories Ltd ADR (RDY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.33B | $65.25B | $50.01B | $69.44B | $70.28B | $74.69B | $96.74B | $116.27B | $132.17B | $148.19B | $154.71B | $140.81B | $142.03B | $153.85B | $174.60B | $2.56B | $214.39B | $245.88B | $279.16B | $325.54B |
| Revenue growth (YoY) | — | +168.2% | -23.4% | +38.9% | +1.2% | +6.3% | +29.5% | +20.2% | +13.7% | +12.1% | +4.4% | -9.0% | +0.9% | +8.3% | +13.5% | -98.5% | +8288.8% | +14.7% | +13.5% | +16.6% |
| Cost of revenue | $12.45B | $34.30B | $24.60B | $32.94B | $33.94B | $34.43B | $43.43B | $55.69B | $56.37B | $62.79B | $62.43B | $62.45B | $65.72B | $70.42B | $80.59B | $1.26B | $100.55B | $106.54B | $115.56B | $135.11B |
| Gross profit | $11.88B | $30.95B | $25.41B | $36.50B | $36.34B | $40.26B | $53.30B | $60.58B | $75.80B | $85.40B | $92.28B | $78.36B | $76.30B | $83.43B | $94.01B | $1.30B | $113.84B | $139.34B | $163.61B | $190.43B |
| Gross margin | 48.8% | 47.4% | 50.8% | 52.6% | 51.7% | 53.9% | 55.1% | 52.1% | 57.4% | 57.6% | 59.6% | 55.6% | 53.7% | 54.2% | 53.8% | 50.8% | 53.1% | 56.7% | 58.6% | 58.5% |
| R&D | $2.16B | $2.47B | $3.53B | $4.04B | $3.79B | $5.06B | $5.91B | $7.67B | $12.40B | $17.45B | $17.83B | $19.55B | $18.27B | $15.61B | $15.41B | $208.37M | $17.48B | $19.38B | $22.87B | $27.38B |
| SG&A | $6.77M | $6.77M | $14.05M | $413.00M | $501.00M | $532.00M | $633.74M | $709.68M | $646.00M | $683.00M | $690.00M | $715.00M | $720.00M | $707.00M | $50.13B | $54.56B | $62.08B | $46.47B | $77.20B | $93.87B |
| Operating income | $1.45B | $11.25B | $3.36B | $-2.83B | $2.01B | $12.63B | $18.25B | $21.11B | $26.03B | $26.29B | $29.62B | $13.50B | $11.92B | $20.89B | $15.99B | $431.44M | $29.48B | $57.14B | $67.73B | $71.84B |
| Operating margin | 5.9% | 17.2% | 6.7% | -4.1% | 2.9% | 16.9% | 18.9% | 18.2% | 19.7% | 17.7% | 19.1% | 9.6% | 8.4% | 13.6% | 9.2% | 16.9% | 13.7% | 23.2% | 24.3% | 22.1% |
| EBITDA | $2.71B | $14.27B | $7.31B | $1.49B | $6.58B | $16.82B | $20.33B | $22.49B | $33.14B | $34.39B | $39.87B | $24.77B | $23.63B | $35.52B | $41.78B | $534.77M | $45.08B | $74.43B | $88.42B | $96.67B |
| EBITDA margin | 11.1% | 21.9% | 14.6% | 2.1% | 9.4% | 22.5% | 21.0% | 19.3% | 25.1% | 23.2% | 25.8% | 17.6% | 16.6% | 23.1% | 23.9% | 20.9% | 21.0% | 30.3% | 31.7% | 29.7% |
| EBIT | $1.14B | $11.25B | $1.10B | $-2.33B | $2.42B | $12.68B | $15.12B | $16.94B | $26.03B | $26.29B | $29.62B | $13.50B | $11.92B | $23.33B | $29.31B | $362.40M | $33.26B | $61.80B | $73.58B | $79.61B |
| Interest expense | $0.00 | $0.00 | $1.08B | $1.67B | $372.00M | $362.00M | $1.07B | $1.02B | $1.27B | $1.09B | $826.00M | $634.00M | $788.00M | $889.00M | $13.86M | $970.00M | $958.00M | $1.43B | $1.71B | $2.83B |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $1.63B | $9.35B | $4.68B | $-5.17B | $1.07B | $11.04B | $14.26B | $16.78B | $21.51B | $22.18B | $20.01B | $12.04B | $9.81B | $18.80B | $19.50B | $232.21M | $23.57B | $45.07B | $55.68B | $56.54B |
| Net income growth (YoY) | — | +472.5% | -50.0% | -210.5% | +120.7% | +933.7% | +29.2% | +17.6% | +28.2% | +3.1% | -9.8% | -39.8% | -18.5% | +91.7% | +3.7% | -98.8% | +10049.5% | +91.2% | +23.6% | +1.5% |
| Profit margin | 6.7% | 14.3% | 9.4% | -7.4% | 1.5% | 14.8% | 14.7% | 14.4% | 16.3% | 15.0% | 12.9% | 8.5% | 6.9% | 12.2% | 11.2% | 9.1% | 11.0% | 18.3% | 19.9% | 17.4% |